Class information for:
Level 1: ANTIHYPERTENSIVE PHARMACOTHERAPY//ACE INHIBITION ECHOCARDIOGRAPHY EXERCISES HEMODYNAMICS//ASYSTEMATIC VERTIGO

Basic class information

Class id #P Avg. number of
references
Database coverage
of references
18303 557 30.1 38%



Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes

The table includes all classes above and classes immediately below the current class.



Cluster id Level Cluster label #P
8 4 CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL 1276458
522 3       MAGNESIUM-BULLETIN//MAGNESIUM RESEARCH//MAGNESIUM 20526
878 2             NEBIVOLOL//CARVEDILOL//BETA BLOCKERS 11463
18303 1                   ANTIHYPERTENSIVE PHARMACOTHERAPY//ACE INHIBITION ECHOCARDIOGRAPHY EXERCISES HEMODYNAMICS//ASYSTEMATIC VERTIGO 557

Terms with highest relevance score



rank Term termType Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 ANTIHYPERTENSIVE PHARMACOTHERAPY authKW 109640 0% 100% 2
2 ACE INHIBITION ECHOCARDIOGRAPHY EXERCISES HEMODYNAMICS authKW 54820 0% 100% 1
3 ASYSTEMATIC VERTIGO authKW 54820 0% 100% 1
4 ATHLETES AND HYPERTENSION authKW 54820 0% 100% 1
5 ATHLETIC CHILDREN authKW 54820 0% 100% 1
6 BETA 2 RECEPTOR TOLERANCE authKW 54820 0% 100% 1
7 BETA BLOCKADE ENDURANCE EXERCISE GLYCEROL NEFA authKW 54820 0% 100% 1
8 BETA BLOCKERS NEGATIVE CHRONOTROPIC EFFECT authKW 54820 0% 100% 1
9 BETA1 SELECTIVE BLOCKADE authKW 54820 0% 100% 1
10 BISPROLOL authKW 54820 0% 100% 1

Web of Science journal categories



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 Sport Sciences 4108 20% 0% 113
2 Cardiac & Cardiovascular System 2265 26% 0% 143
3 Physiology 1129 16% 0% 90
4 Pharmacology & Pharmacy 675 22% 0% 123
5 Peripheral Vascular Diseases 392 8% 0% 47
6 Medicine, General & Internal 371 13% 0% 74
7 Medicine, Research & Experimental 59 5% 0% 28
8 Primary Health Care 54 1% 0% 6
9 Rehabilitation 19 2% 0% 9
10 Critical Care Medicine 12 1% 0% 7

Address terms



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 CEDENA 54820 0% 100% 1
2 FT BELVOIR COMMUNITY HOSP 54820 0% 100% 1
3 GEMELLI POLICLIN IST PATOL MED 54820 0% 100% 1
4 HKLIN HERZ KREISLAUFKRANKHEITEN ORTHOPED 54820 0% 100% 1
5 HLTH PHYS EDUC RECREAT DANCE BIOKINET 54820 0% 100% 1
6 JAMES A TAYLOR CAMPUS HLTH SERV 54820 0% 100% 1
7 MED PHARMACOL EXERCISE SCI 54820 0% 100% 1
8 SERV EPIDEMIOL EVOLUT CLIN 54820 0% 100% 1
9 UNC SPORTS MED 54820 0% 100% 1
10 UNIV LEUVENUZ GASTHUISBERG 54820 0% 100% 1

Journals



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 HERZ KREISLAUF 9476 2% 1% 13
2 CLINICAL PHYSIOLOGY 6251 2% 1% 12
3 INTERNATIONAL JOURNAL OF SPORTS MEDICINE 6192 4% 1% 22
4 BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 5657 5% 0% 29
5 AMERICAN JOURNAL OF CARDIOLOGY 4328 8% 0% 46
6 EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 2489 3% 0% 18
7 ZEITSCHRIFT FUR KARDIOLOGIE 2277 2% 0% 13
8 ACTA PHYSIOLOGICA SCANDINAVICA 2239 3% 0% 15
9 EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY AND OCCUPATIONAL PHYSIOLOGY 2091 1% 0% 8
10 JOURNAL OF APPLIED PHYSIOLOGY 1755 5% 0% 26

Author Key Words



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
LCSH search Wikipedia search
1 ANTIHYPERTENSIVE PHARMACOTHERAPY 109640 0% 100% 2 Search ANTIHYPERTENSIVE+PHARMACOTHERAPY Search ANTIHYPERTENSIVE+PHARMACOTHERAPY
2 ACE INHIBITION ECHOCARDIOGRAPHY EXERCISES HEMODYNAMICS 54820 0% 100% 1 Search ACE+INHIBITION+ECHOCARDIOGRAPHY+EXERCISES+HEMODYNAMICS Search ACE+INHIBITION+ECHOCARDIOGRAPHY+EXERCISES+HEMODYNAMICS
3 ASYSTEMATIC VERTIGO 54820 0% 100% 1 Search ASYSTEMATIC+VERTIGO Search ASYSTEMATIC+VERTIGO
4 ATHLETES AND HYPERTENSION 54820 0% 100% 1 Search ATHLETES+AND+HYPERTENSION Search ATHLETES+AND+HYPERTENSION
5 ATHLETIC CHILDREN 54820 0% 100% 1 Search ATHLETIC+CHILDREN Search ATHLETIC+CHILDREN
6 BETA 2 RECEPTOR TOLERANCE 54820 0% 100% 1 Search BETA+2+RECEPTOR+TOLERANCE Search BETA+2+RECEPTOR+TOLERANCE
7 BETA BLOCKADE ENDURANCE EXERCISE GLYCEROL NEFA 54820 0% 100% 1 Search BETA+BLOCKADE+ENDURANCE+EXERCISE+GLYCEROL+NEFA Search BETA+BLOCKADE+ENDURANCE+EXERCISE+GLYCEROL+NEFA
8 BETA BLOCKERS NEGATIVE CHRONOTROPIC EFFECT 54820 0% 100% 1 Search BETA+BLOCKERS+NEGATIVE+CHRONOTROPIC+EFFECT Search BETA+BLOCKERS+NEGATIVE+CHRONOTROPIC+EFFECT
9 BETA1 SELECTIVE BLOCKADE 54820 0% 100% 1 Search BETA1+SELECTIVE+BLOCKADE Search BETA1+SELECTIVE+BLOCKADE
10 BISPROLOL 54820 0% 100% 1 Search BISPROLOL Search BISPROLOL

Core articles

The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.



Rank Reference # ref.
in cl.
Shr. of ref. in
cl.
Citations
1 KINDERMANN, W , (1998) ANTIHYPERTENSIVE DIFFERENTIAL THERAPY IN PHYSICALLY ACTIVE SUBJECTS.HERZ KREISLAUF. VOL. 30. ISSUE 9. P. 298-305 30 77% 0
2 TESCH, PA , (1985) EXERCISE PERFORMANCE AND BETA-BLOCKADE.SPORTS MEDICINE. VOL. 2. ISSUE 6. P. 389-412 50 69% 55
3 HEAD, A , (1999) EXERCISE METABOLISM AND BETA-BLOCKER THERAPY - AN UPDATE.SPORTS MEDICINE. VOL. 27. ISSUE 2. P. 81 -96 38 48% 17
4 PEKKARINEN, H , RANDELL, J , STORSKRUBB, T , LANSIMIES, E , UUSITUPA, M , (2000) EFFECT OF A SINGLE-DOSE NON-SELECTIVE BETA BLOCKING AGENT ON MAXIMAL CYCLE EXERCISE; A RANDOMIZED PLACEBO CONTROLLED STUDY.BIOLOGY OF SPORT. VOL. 17. ISSUE 4. P. 233-243 17 85% 0
5 MCKELVIE, RS , JONES, NL , HEIGENHAUSER, GJF , (1991) FACTORS CONTRIBUTING TO INCREASED MUSCLE FATIGUE WITH BETA-BLOCKERS.CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY. VOL. 69. ISSUE 2. P. 254-261 31 65% 7
6 ASPLUND, C , (2010) TREATMENT OF HYPERTENSION IN ATHLETES: AN EVIDENCE-BASED REVIEW.PHYSICIAN AND SPORTSMEDICINE. VOL. 38. ISSUE 1. P. 37 -44 19 50% 4
7 JESEK, JK , MARTIN, NB , BROEDER, CE , THOMAS, EL , WAMBSGANS, KC , HOFMAN, Z , IVY, JL , WILMORE, JH , (1990) CHANGES IN PLASMA-FREE FATTY-ACIDS AND GLYCEROLS DURING PROLONGED EXERCISE IN TRAINED AND HYPERTENSIVE PERSONS TAKING PROPRANOLOL AND PINDOLOL.AMERICAN JOURNAL OF CARDIOLOGY. VOL. 66. ISSUE 19. P. 1336-1341 18 95% 11
8 TEIXEIRA, A , BILLIGMANN, PW , BOHNER, H , SCHUMACHER, H , (1992) EXERCISE PERFORMANCE AFTER LONG-TERM ADMINISTRATION OF ENALAPRIL OR METOPROLOL - A RANDOMIZED DOUBLE-BLIND TRIAL IN LEISURE-TIME SPORTSMEN.DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT. VOL. 117. ISSUE 25. P. 967-973 19 83% 3
9 VANBAAK, MA , (1994) HYPERTENSION, BETA-ADRENOCEPTOR BLOCKING-AGENTS AND EXERCISE.INTERNATIONAL JOURNAL OF SPORTS MEDICINE. VOL. 15. ISSUE 3. P. 112-115 16 80% 6
10 VANHEES, L , DEFOOR, JGM , SCHEPERS, D , LIJNEN, P , PEETERS, BYM , LACANTE, PHL , FAGARD, RH , (2000) EFFECT OF BISOPROLOL AND ATENOLOL ON ENDURANCE EXERCISE CAPACITY IN HEALTHY MEN.JOURNAL OF HYPERTENSION. VOL. 18. ISSUE 1. P. 35-43 17 57% 24

Classes with closest relation at Level 1



Rank Class id link
1 20681 CELIPROLOL//PERINDOPRIL THERAPEUTIC USE//1 BETA ADRENERGIC RECEPTOR
2 30014 ADAPTATIONS TO EXERCISE//ANESTHESIA ELECTROSTIMULATION//COMPLIANCE DIETARY
3 23518 POLYVINYLACETATE POVIDONE EXCIPIENT//RECEPTOR OCCUPANCY THEORY//CAS 318 98 9
4 12676 AMOSULALOL//DILEVALOL//AARHUS CTY HOSP MED 1
5 18811 BISOPROLOL//BISOPROLOL EFFICACY//INTRAVESICAL BCG INSTILLATION
6 34799 CARDIOPULMONARY NORMAL VALUES//WATT REFERENCE VALUE//CT CONTRAST
7 18914 EXERCISE BLOOD PRESSURE//HYPERTENSIVE RESPONSE TO EXERCISE//EXAGGERATED BLOOD PRESSURE RESPONSE
8 10623 POST EXERCISE HYPOTENSION//POSTEXERCISE HYPOTENSION//EXERCISE HEMODYNAM
9 36723 ABT KARDIOLMED KLIN POLIKLIN//ANCIENT MODERN BALL GAMES//ANTERIOR LARGE LEFT VENTRICULAR DYSFUNCTION TRAINING PRESCRIPTION
10 16705 DEPRESSIVE DISORDER CHEMICALLY INDUCED//DRUG INDUCED DEPRESSION//2 DIMENSIONAL OUTCOME

Go to start page